Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CCG-222740
Cat. No.:
OB0225LY-0049
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
CCG-222740 is a novel selective inhibitor with a unique targeting action.
Synonym:
1922098-69-8; N-(4-Chlorophenyl)-5,5-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide; N-(4-Chlorophenyl)-5,5-difluoro-1-[3-(furan-2-yl)benzoyl]piperidine-3-carboxamide
CAS No.:
1922098-69-8
Compound CID:
121317937
Formula:
C23H19ClF2N2O3
Formula Weight:
444.86
Specification
Relative Density:
1.40 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
CCG-222740 can be used to explore cell signaling and its effect on tumor cell proliferation.
Library Information
Targets:
GTPase superfamily; Serine/threonine kinases
Receptors:
Ras; Rho; ROCK
Pathways:
MAPK; GPCR/G protein; Cell cycle/Checkpoint; Stem cells; Cytoskeletal signaling
Plate Number:
AOCL-1
Plate Location:
e11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
125 mg/mL; 280.99 Mm
